Development and Initial Testing of the Stroke Rapid-Treatment Readiness Tool

No instruments are currently available to help health systems identify target areas for reducing door-to-needle times for the administration of intravenous tissue plasminogen activator to eligible patients with ischemic stroke. A 67-item Likert-scale survey was administered by telephone to stroke pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Olson, DaiWai M., Cox, Margueritte, Constable, Mark, Britz, Gavin W., Lin, Cheryl B., Zimmer, Louise O., Fonarow, Gregg C., Schwamm, Lee H., Peterson, Eric D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association of Neuroscience Nurses 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165480/
https://www.ncbi.nlm.nih.gov/pubmed/25099063
http://dx.doi.org/10.1097/JNN.0000000000000082
Descripción
Sumario:No instruments are currently available to help health systems identify target areas for reducing door-to-needle times for the administration of intravenous tissue plasminogen activator to eligible patients with ischemic stroke. A 67-item Likert-scale survey was administered by telephone to stroke personnel at 252 U.S. hospitals participating in the “Get With The Guidelines-Stroke” quality improvement program. Factor analysis was used to refine the instrument to a four-factor 29-item instrument that can be used by hospitals to assess their readiness to administer intravenous tissue plasminogen activator within 60 minutes of patient hospital arrival.

Ejemplares similares